Abstract
Voriconazole is an antifungal widely used in the treatment of invasive fungal infections, thus pharmacokinetic monitoring is highly important to achieve appropriate dosages. It has been described that patients undergoing continuous renal replacement therapy did not see plasma voriconazole concentrations altered. Two cases are presented in which subtherapeutic voriconazole plasma levels are obtained while the patients are in continuous venovenous hemodiafiltration.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Analytical & Pharmaceutical Research
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
